Login / Signup

Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool.

Kelly-Anne PhillipsYuyan LiaoJonathan BeesleyRobert J MacInnisIan M CollinsRichard BuchsbaumPrue C WeidemanAdrian BickerstaffeStephanie NesciWendy K ChungMelissa C SoutheyJulia A KnightAlice S WhittemoreGillian S DiteDavid GoldgarGraham G GilesGord GlendonJack CuzickAntonis C AntoniouIrene L AndrulisEsther M JohnMary B DalySaundra S BuysJohn L HopperMary Beth Terrynull null
Published in: JNCI cancer spectrum (2019)
For 10-year BC risk, iPrevent had good discriminatory accuracy overall and was well calibrated for women aged younger than 50 years. Calibration may be improved in the future by incorporating IBIS version 8.0b.
Keyphrases
  • risk assessment
  • breast cancer risk
  • polycystic ovary syndrome
  • type diabetes
  • skeletal muscle
  • pregnancy outcomes
  • low cost
  • psychometric properties